article

Basic Pharmacology: How Methadone Works? by J.T. Payte, Jeffrey Smith and Joycelyn Woods

Time to read: 1 min

J. Thomas Payte, M.D. is Medical Director and Founder of Drug Dependence Associates in San Antonio, Texas, Chair of the Maintenance Medications Committee of the American Society of Addiction Medicine and a member of NAMAs Advisory Board.

Jeffrey Smith, Ph.D. has a degree is central nervous system pharmacology.

Joycelyn Woods, M.A. is President of NAMA. Her degree is in neurological psychology and she had done brain mapping of opiate receptors and published one of the early papers on it.

Index

PART I	PART II	PART III
The Basics of Pharmacology	The Pharmacology of Opioids	Drugs and Conditions That Impact On the Action of Methadone
Download PDF File Part 1	Download PDF File Part 2	Download PDF File Part 3

article

We Speak Methadone (and buprenorphine) – Index page
ByAdmin 04/02/202206/26/2023
Admin 04/02/2022

View unanswered posts | View active topics Board index All times are UTC – 5 hours Forum Topics Posts Last post We Speak Methadone (and Buprenorphine) Message Boards Medication Assisted Treatment Main Forum Information on treatment and advocacy, open discussions, and anything else MAT-related! Moderators: sapphire, tndirector 95 643 Fri Jan 29, 2016…

Read More We Speak Methadone (and buprenorphine) – Index page
article

Take Home Regulation Page 4098
ByAdmin 05/06/202106/26/2023
Admin 05/06/2021

Page 4098 Federal Register Vol. 66, No. 11 / Wednesday, January 17, 2001 / Rules and Regulations (i) Unsupervised or “take-home” use. To limit the potential for diversion of opioid agonist treatment medications to the illicit market, opioid agonist treatment medications dispensed to patients for unsupervised use shall be subject to the following requirements. (1)…

Read More Take Home Regulation Page 4098
article

Federal Agencies
ByAdmin 10/16/202206/26/2023
Admin 10/16/2022

United States Regulations Code of Federal Regulations 42 Part 8. Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction. Federal Register 17 January 2001. (PDF Format) Publication of Final Rule with comments. 42 Code of Federal Regulations Part 2 . Confidentiality of Alcohol and Drug Abuse Patient Records. New Take Home Regulations. Page 4098…

Read More Federal Agencies
article

Lindesmith Center Seminar Schedule
ByAdmin 08/05/202206/26/2023
Admin 08/05/2022

The Lindesmith Center’s SPECIAL DRUG POLICY SEMINAR SERIES Summer and Fall 1996 DRUG TREATMENT RECONSIDERED: HARM REDUCTION PERSPECTIVES The Lindesmith Center is presenting a special seminar series on the relationship between drug treatment and harm reduction. Harm reduction services focus on reducing the negative consequences of drug use among those unwilling or unable to abstain….

Read More Lindesmith Center Seminar Schedule
article

Responsible Methadone Advocacy
ByAdmin 03/17/202306/26/2023
Admin 03/17/2023

First the ground rules! In every thing NAMA does the rights and dignity of the individual patient take precedence. It is never, ever, OK to violate that rule no matter how important the issue. NAMA has not and will never serve as an apologist for poor treatment. Everyone whether you want to be a NAMA …

Read More Responsible Methadone Advocacy
article

Citation Instructions
ByAdmin 03/14/202304/19/2024
Admin 03/14/2023

NAMA produces materials for education and disemination. You are free to use them in your publications, or to discribute them. These are intended only as examples. Education Series author, name of document. Education Series, Number X, date. Available from National Alliance of Methadone Advocates, 435 Second Avenue, New York, NY 10010. Policy Statement name of…

Read More Citation Instructions